Janney Montgomery Scott LLC boosted its position in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) by 4.7% during the second quarter, Holdings Channel reports. The firm owned 39,260 shares of the medical equipment provider’s stock after buying an additional 1,768 shares during the period. Janney Montgomery Scott LLC’s holdings in Smith & Nephew SNATS were worth $1,368,000 at the end of the most recent quarter.
Several other hedge funds have also recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Smith & Nephew SNATS by 0.5% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 3,408 shares of the medical equipment provider’s stock worth $106,000 after buying an additional 17 shares during the period. Paloma Partners Management Co purchased a new stake in shares of Smith & Nephew SNATS during the first quarter worth about $200,000. Greenleaf Trust purchased a new stake in shares of Smith & Nephew SNATS during the second quarter worth about $207,000. RMB Capital Management LLC purchased a new stake in shares of Smith & Nephew SNATS during the first quarter worth about $219,000. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Smith & Nephew SNATS during the first quarter worth about $224,000. 7.23% of the stock is owned by hedge funds and other institutional investors.
Shares of Smith & Nephew SNATS, Inc. (NYSE SNN) opened at 34.99 on Friday. The company has a 50 day moving average price of $34.91 and a 200-day moving average price of $32.95. The firm has a market capitalization of $15.32 billion, a PE ratio of 17.82 and a beta of 0.76. Smith & Nephew SNATS, Inc. has a 12 month low of $26.97 and a 12 month high of $35.85.
TRADEMARK VIOLATION WARNING: This report was first posted by Ticker Report and is the property of of Ticker Report. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.tickerreport.com/banking-finance/2801609/smith-nephew-snats-inc-snn-position-raised-by-janney-montgomery-scott-llc.html.
A number of brokerages recently issued reports on SNN. Zacks Investment Research raised Smith & Nephew SNATS from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a research report on Tuesday, July 11th. BidaskClub cut Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a research report on Tuesday, July 25th. Four equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $38.00.
Smith & Nephew SNATS Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew SNATS, Inc. (NYSE:SNN).
Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.